A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial

Brendan P Jacka, Jacqueline E Goldman, Jesse L Yedinak, Edward Bernstein, Scott E Hadland, Jane A Buxton, Susan G Sherman, Katie B Biello, Brandon D L Marshall, Brendan P Jacka, Jacqueline E Goldman, Jesse L Yedinak, Edward Bernstein, Scott E Hadland, Jane A Buxton, Susan G Sherman, Katie B Biello, Brandon D L Marshall

Abstract

Background: Opioid overdose deaths involving synthetic opioids, particularly illicitly manufactured fentanyl, remain a substantial public health concern in North America. Responses to overdose events (e.g., administration of naloxone and rescue breathing) are effective at reducing mortality; however, more interventions are needed to prevent overdoses involving illicitly manufactured fentanyl. This study protocol aims to evaluate the effectiveness of a behavior change intervention that incorporates individual counseling, practical training in fentanyl test strip use, and distribution of fentanyl test strips for take-home use among people who use drugs.

Methods: Residents of Rhode Island aged 18-65 years who report recent substance use (including prescription pills obtained from the street; heroin, powder cocaine, crack cocaine, methamphetamine; or any drug by injection) (n = 500) will be recruited through advertisements and targeted street-based outreach into a two-arm randomized clinical trial with 12 months of post-randomization follow-up. Eligible participants will be randomized (1:1) to receive either the RAPIDS intervention (i.e., fentanyl-specific overdose education, behavior change motivational interviewing (MI) sessions focused on using fentanyl test strips to reduce overdose risk, fentanyl test strip training, and distribution of fentanyl test strips for personal use) or standard overdose education as control. Participants will attend MI booster sessions (intervention) or attention-matched control sessions at 1, 2, and 3 months post-randomization. All participants will be offered naloxone at enrolment. The primary outcome is a composite measure of self-reported overdose in the previous month at 6- and/or 12-month follow-up visit. Secondary outcome measures include administratively linked data regarding fatal (post-mortem investigation) and non-fatal (hospitalization or emergency medical service utilization) overdoses.

Discussion: If the RAPIDS intervention is found to be effective, its brief MI and fentanyl test strip training components could be easily incorporated into existing community-based overdose prevention programming to help reduce the rates of fentanyl-related opioid overdose.

Trial registration: ClinicalTrials.gov NCT04372238 . Registered on 01 May 2020.

Keywords: Behavioral intervention; Fentanyl test strip; Illicitly manufactured fentanyl; Information-motivation-behavioral model; Motivational interviewing; Opioid overdose; Overdose prevention; Randomized controlled trial.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Study plan schematic of the RAPIDS Clinical Trial for the prevention of opioid overdose among people who use drugs
Fig. 2
Fig. 2
Conceptual model of the RAPIDS intervention for the prevention of opioid overdose among people who use drugs

References

    1. Wilson N, Kariisa M, Seth P, Smith H, 4th, Davis NL. Drug and opioid-involved overdose deaths - United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290–297. doi: 10.15585/mmwr.mm6911a4.
    1. Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560–1579. doi: 10.1016/S0140-6736(19)32229-9.
    1. Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183–188. doi: 10.1016/j.drugpo.2019.01.010.
    1. LaRue L, Twillman RK, Dawson E, Whitley P, Frasco MA, Huskey A, et al. Rate of fentanyl positivity among urine drug test results positive for cocaine or methamphetamine. JAMA Netw Open. 2019;2(4):e192851. doi: 10.1001/jamanetworkopen.2019.2851.
    1. Gladden RM, O’Donnell J, Mattson CL, Seth P. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine - 25 states, July-December 2017 to January-June 2018. MMWR Morb Mortal Wkly Rep. 2019;68(34):737–744. doi: 10.15585/mmwr.mm6834a2.
    1. Bardwell G, Kerr T. Drug checking: a potential solution to the opioid overdose epidemic? Subst Abuse Treat Prev Policy. 2018;13(1):20. doi: 10.1186/s13011-018-0156-3.
    1. Wallace B, Pagan F, Pauly BB. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency. Int J Drug Policy. 2019;66:64–72. doi: 10.1016/j.drugpo.2019.01.017.
    1. Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137–145. doi: 10.7326/M17-3107.
    1. McKnight C, Des Jarlais DC. Being “hooked up” during a sharp increase in the availability of illicitly manufactured fentanyl: adaptations of drug using practices among people who use drugs (PWUD) in New York City. Int J Drug Policy. 2018;60:82–88. doi: 10.1016/j.drugpo.2018.08.004.
    1. Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J. 2018;15(1):26. doi: 10.1186/s12954-018-0232-z.
    1. McGowan CR, Harris M, Platt L, Hope V, Rhodes T. Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: do we know enough to promote it? Int J Drug Policy. 2018 Aug;58:31–36.
    1. Harper L, Powell J, Pijl EM. An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services. Harm Reduct J. 2017;14(1):52. doi: 10.1186/s12954-017-0179-5.
    1. Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Int J Drug Policy. 2020;77:102661. doi: 10.1016/j.drugpo.2020.102661.
    1. Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):7. doi: 10.1186/s12954-018-0213-2.
    1. Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Int J Drug Policy. 2019;68:46–53. doi: 10.1016/j.drugpo.2019.03.003.
    1. Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BDL. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16(1):3. doi: 10.1186/s12954-018-0276-0.
    1. Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122–128. doi: 10.1016/j.drugpo.2018.08.007.
    1. Marshall BDL, Krieger MS, Yedinak JL, Ogera P, Banerjee P, Alexander-Scott NE, et al. Epidemiology of fentanyl-involved drug overdose deaths: a geospatial retrospective study in Rhode Island, USA. Int J Drug Policy. 2017;46:130–135. doi: 10.1016/j.drugpo.2017.05.029.
    1. Yokell MA, Green TC, Bowman S, McKenzie M, Rich JD. Opioid overdose prevention and naloxone distribution in Rhode Island. Med Health R I. 2011;94(8):240–242.
    1. Fisher WA, Fisher JD, Harman J. The information-motivation-behavioraI skills model: a general social psychological approach to understanding and promoting health behavior. Soc Psychol Foundations Health Illness. 2003;583:82–106. doi: 10.1002/9780470753552.ch4.
    1. Brown W, 3rd, Carballo-Diéguez A, John RM, Schnall R. Information, motivation, and behavioral skills of high-risk young adults to use the HIV self-test. AIDS Behav. 2016;20(9):2000–2009. doi: 10.1007/s10461-016-1309-x.
    1. Phillips KT, Altman JK, Corsi KF, Stein MD. Development of a risk reduction intervention to reduce bacterial and viral infections for injection drug users. Subst Use Misuse. 2013;48(1–2):54–64. doi: 10.3109/10826084.2012.722159.
    1. Fisher CM. Adapting the information-motivation-behavioral skills model: predicting HIV-related sexual risk among sexual minority youth. Health Educ Behav. 2012;39(3):290–302. doi: 10.1177/1090198111406537.
    1. Stein MD, Charuvastra A, Maksad J, Anderson BJ. A randomized trial of a brief alcohol intervention for needle exchangers (BRAINE) Addiction. 2002;97(6):691–700. doi: 10.1046/j.1360-0443.2002.00102.x.
    1. Fernandez WG, Mitchell PM, Jamanka AS, Winter MR, Bullock H, Donovan J, et al. Brief motivational intervention to increase self-reported safety belt use among emergency department patients. Acad Emerg Med. 2008;15(5):419–425. doi: 10.1111/j.1553-2712.2008.00096.x.
    1. Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R. Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend. 2005;77(1):49–59. doi: 10.1016/j.drugalcdep.2004.07.006.
    1. Miller WR, Rollnick S. Motivational interviewing: helping people change. 3. New York, NY, US: Guilford Press; 2012.
    1. Miller WR, Moyers TB. Eight stages in learning motivational interviewing. J Teach Addictions. 2006;5(1):3–17. doi: 10.1300/J188v05n01_02.
    1. Caudarella A, Dong H, Milloy MJ, Kerr T, Wood E, Hayashi K. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51–55. doi: 10.1016/j.drugalcdep.2016.02.024.
    1. Escudero DJ, Marshall BDL, Kerr T, Hayashi K, Feng C, Guillemi SA, et al. No association between HIV status and risk of non-fatal overdose among people who inject drugs in Vancouver, Canada. Addict Behav. 2016;60:8–12. doi: 10.1016/j.addbeh.2016.03.029.
    1. Suzuki J, El-Haddad S. A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017;171:107–116. doi: 10.1016/j.drugalcdep.2016.11.033.
    1. Evans TI, Hadland SE, Clark MA, Green TC, Marshall BDL. Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Harm Reduct J. 2016;13(1):24. doi: 10.1186/s12954-016-0113-2.
    1. Jelsma JGM, Mertens V-C, Forsberg L, Forsberg L. How to measure motivational interviewing fidelity in randomized controlled trials: practical recommendations. Contemp Clin Trials. 2015;43:93–99. doi: 10.1016/j.cct.2015.05.001.
    1. Lasher L, Rhodes J, Viner-Brown S. Identification and description of non-fatal opioid overdoses using Rhode Island EMS data, 2016-2018. R I Med J. 2019;102(2):41–45.
    1. DeMets DL, Lan KK. Interim analysis: the alpha spending function approach. Stat Med. 1994;13(13–14):1341–1352. doi: 10.1002/sim.4780131308.
    1. Marshall BDL, Green TC, Elston B, Yedinak JL, Hadland SE, Clark MA. The effectiveness of internet- and field-based methods to recruit young adults who use prescription opioids nonmedically. Subst Use Misuse. 2018;53(10):1688–1699. doi: 10.1080/10826084.2018.1425725.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner